CHERYL HERRLE: Open Payments
NPI 1003285966 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,457 in 46 payments from 9 companies in 2025. Trend: 2023 $867 · 2024 $1,740 · 2025 $1,457
Food & beverage: $1,457
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 28 | $503 |
| Novo Nordisk Inc | 2 | $231 |
| Sequel Med Tech, LLC | 2 | $206 |
| Corcept Therapeutics | 8 | $187 |
| Medtronic, Inc. | 1 | $133 |
| Tandem Diabetes Care, Inc. | 1 | $120 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: Dexcom G6 Transmitter, TWIIST, Korlym, MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, LEQVIO, Kerendia, MOUNJARO.
Industry payments across OH — which companies pay providers there.
